AbbVie spends $60M, with $805M in biobucks, for Alpine Immune's lupus asset Pfizer, Sangamo flesh out hemophilia gene therapy data ahead of phase 3 BioMarin’s hemophilia gene therapy ‘Roc solid’ after 4 years Sponsored: NYC Biotechs Rally to Test for COVID-19 Dicerna nabs speedy review voucher for leading RNAi drug Sponsored: The Future of Clinical Research: Digitally Transforming What’s Possible Ubiquigent DUB inhibitor pact survives Bristol-Celgene merger Treating age-related diseases with a CAR-T that targets 'senescent' cells Digital pill developer Proteus files for bankruptcy Featured Story | Thursday, June 18, 2020 AbbVie is spending $60 million upfront for a midstage lupus and autoimmune asset currently developed by Alpine Immune. read more |
| |
|---|
|
Top Stories Thursday, June 18, 2020 There’s a pivotal trial in the offing for Pfizer and Sangamo’s hemophilia A gene therapy, but, in the meantime, the duo is unveiling updated phase 1/2 data. The highest dose of the treatment helped patients make functioning blood-clotting factors for a sustained period, underlining its potential to free hemophilia A patients from lifelong treatment. read more Thursday, June 18, 2020 Four years on, BioMarin’s hemophilia A gene therapy is still going strong—it staved off bleeding episodes in patients with hemophilia A and reduced their reliance on infusions of a blood-clotting factor that they lack. read more Monday, June 15, 2020 Hit hard by COVID-19, five NYC biotech companies develop innovative diagnostic technologies that provide faster and better tests. read more Thursday, June 18, 2020 RNA biotech Dicerna has nabbed a priority review voucher as part of its new rare pediatric disease designation for leading drug nedosiran. read more Monday, June 15, 2020 Sponsors are transforming and future-proofing their clinical research by incorporating virtual options in study protocols. Discover why patients are key to the success of these digital strategies. read more Thursday, June 18, 2020 Bristol Myers Squibb is continuing a drug discovery collaboration with Ubiquigent that it inherited in its merger with Celgene. The Big Pharma recently scrapped an alliance with Jounce Therapeutics that was formed by Celgene but is sticking with deubiquitinase (DUB) enzyme specialist Ubiquigent. read more Thursday, June 18, 2020 Many age-related diseases like liver fibrosis and diabetes have been partly attributed to cellular "senescence," a zombie-like state in which cells stop proliferating. A team at Memorial Sloan Kettering Cancer Center is targeting these diseases with CAR-T cells that are designed to clear senescent cells. read more Wednesday, June 17, 2020 Proteus Digital Health—makers of an ingestible sensor embedded within a pill to track medication usage—has filed for bankruptcy, after failing to raise funding in part due to the COVID-19 pandemic. read more Enrollment Showcase | Sponsored by: University of Florida College of Pharmacy Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program. |
| |
|---|
|
Resources Sponsored by: Cenduit Download this case study to read how Cenduit helped one client successfully navigate mid-study changes to medication management. Sponsored by: Research Solutions Learn four ways to squeeze more value from your limited R&D resources. Sponsored by: BioAnalytix Download this eBook and Learn the Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies Sponsored by: Catalent In a series of innovation sessions, Catalent RP Scherer softgel capsules were quickly identified as the ideal solution to drive incremental growth. Learn more. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe. Sponsored by: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored by: Clinical Ink Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19. Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Presented by: ICON Clinical Research Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Clarify Health Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Sponsored by: Outer Edge Technology Businesses must maintain pre-pandemic levels of productivity with smaller IT budgets. Learn why an effective Cloud Strategy is imperative for success in these unprecedented times. Medical Affairs Strategic Summit (MASS) East April 14-16, 2020 | New Brunswick, NJ PEGS Virtual Interactive Summit Virtual Event | June 2-26, 2020 European Healthcare Compliance Certificate Program June 2-5, 2020 | Paris, France Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training is in session. | Take your new medicine development skills to the next level. | 